Literature DB >> 27889826

Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.

Christoffer B Nissen1,2, Kim Hørslev-Petersen3,4, Jette Primdahl3,5,4,6.   

Abstract

The objective of the study was to investigate the frequency of traditional risk factors for the cardiovascular (CV) disease, to calculate the Systematic COronary Risk Evaluation (SCORE) for CV-related mortality in Danish patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS), and to compare with results from patients with rheumatoid arthritis (RA) from the same settlement. All PsA and AS patients aged 18-85 years from one outpatient clinic were invited. A rheumatology nurse conducted 30-min screening consultation, preceded by a lipid and glucose profile. High SCORE risk led to recommendation of follow-up by general practitioners. Multiple and logistic regression analyses, adjusted for age and gender, were performed, to compare risk factors and risk SCOREs. Participants were 116 AS (29.3% female) and 170 PsA (54.7% female). AS had opposed PsA patients' lower 10-year risk SCOREs of CV mortality than RA patients: AS versus RA coefficient -0.47 (confidence interval (CI) 95%: -0.84 to -0.) and PsA versus RA -0.14, (-0.43-0.16). Women with PsA and AS had increased waistline compared to women with RA [PsA vs. RA 7.94 (4.51-11.38); AS versus RA 6.67 (1.17-12.17)], and an increased prevalence of hypertension was seen in AS versus RA patients [1.87 (1.15-3.05)]. Traditional, modifiable CV risk factors were present in PsA and AS patients. AS but not PsA patients had an estimated lower 10-year risk of CV mortality than RA patients, according to the SCORE model adjusted for age and gender.

Entities:  

Keywords:  Ankylosing spondylitis; Cardiovascular risk; Psoriatic arthritis; Rheumatoid arthritis; Risk assessment; SCORE

Mesh:

Year:  2016        PMID: 27889826     DOI: 10.1007/s00296-016-3614-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.

Authors:  Ivette Essers; Carmen Stolwijk; Annelies Boonen; Marie L De Bruin; Marloes T Bazelier; Frank de Vries; Astrid van Tubergen
Journal:  Ann Rheum Dis       Date:  2014-10-31       Impact factor: 19.103

2.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

3.  On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.

Authors:  Agnete Malm Gulati; Anne Grete Semb; Silvia Rollefstad; Pål R Romundstad; Arthur Kavanaugh; Sasha Gulati; Glenn Haugeberg; Mari Hoff
Journal:  Ann Rheum Dis       Date:  2015-03-26       Impact factor: 19.103

4.  Mortality in psoriatic arthritis - a single-center study from the UK.

Authors:  Caitriona Buckley; Charlotte Cavill; Gordon Taylor; Hazel Kay; Nicola Waldron; Eleanor Korendowych; Neil McHugh
Journal:  J Rheumatol       Date:  2010-08-03       Impact factor: 4.666

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Patients with early arthritis consume less alcohol than controls, regardless of the type of arthritis.

Authors:  Annekoos L Huidekoper; Diane van der Woude; Rachel Knevel; Annette H M van der Helm-van Mil; Suzanne C Cannegieter; Frits R Rosendaal; Margreet Kloppenburg; Tom W J Huizinga
Journal:  Rheumatology (Oxford)       Date:  2013-06-20       Impact factor: 7.580

7.  Time trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study.

Authors:  Kerry A Wright; Cynthia S Crowson; Clement J Michet; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

8.  Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

Authors:  O Ahlehoff; G H Gislason; M Charlot; C H Jørgensen; J Lindhardsen; J B Olesen; S Z Abildstrøm; L Skov; C Torp-Pedersen; P R Hansen
Journal:  J Intern Med       Date:  2010-11-29       Impact factor: 8.989

9.  Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations.

Authors:  Jette Primdahl; Joan Clausen; Kim Hørslev-Petersen
Journal:  Ann Rheum Dis       Date:  2013-07-12       Impact factor: 19.103

10.  Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.

Authors:  Silvia Rollefstad; Tore K Kvien; Ingar Holme; Anne S Eirheim; Terje R Pedersen; Anne Grete P Semb
Journal:  Ann Rheum Dis       Date:  2012-12-22       Impact factor: 19.103

View more
  3 in total

1.  Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.

Authors:  Erkan Cure; Abdullah Icli; Ali Ugur Uslu; Davut Sakiz; Medine Cumhur Cure; Rabia Aydogan Baykara; Fatma Yavuz; Sevket Arslan; Adem Kucuk
Journal:  Clin Rheumatol       Date:  2018-02-12       Impact factor: 2.980

2.  Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study.

Authors:  Yannick Degboé; Richard Koch; Laurent Zabraniecki; Bénédicte Jamard; Guillaume Couture; Jean Bernard Ruidavets; Jean Ferrieres; Adeline Ruyssen-Witrand; Arnaud Constantin
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study.

Authors:  Jean W Liew; John D Reveille; Maria Castillo; Henna Sawhney; Benjamin S Naovarat; Susan R Heckbert; Lianne S Gensler
Journal:  J Rheumatol       Date:  2020-07-01       Impact factor: 4.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.